KDR and neoplasm: Similarly, the peptide A7R (ATWLPPR) specifically binds to NRP1, has anti-angiogenic activity in vitro by inhibiting NRP1/VEGFR2 signaling, and curbs tumor angiogenesis and tumor growth in vivo [174,368].